跳至主要内容
临床试验/NCT03540446
NCT03540446Unknown不适用

To Prove the Effectiveness of PENS Therapy With Peripheral Neuropathy

DyAnsys, Inc.1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2018年4月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
DyAnsys, Inc.
入组人数
66
试验地点
1
主要终点
Reduction of Neuropathy pain

研究概览

简要总结

To prove the effectiveness of Percutaneous Electrical Neuro-stimulation therapy for the treatment of conditions associated with peripheral neuropathy, in a double-blind environment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with Neuropathy pain

排除标准

  • •Patient with inbuilt pacemakers or any other devices which allows current into the body, pregnant ladies.

研究组 & 干预措施

Standard stimulation

Experimental

Group A will be treated with First Relief Treatment at standard stimulation.

干预措施: First Relief Treatment (Device)

sweep stimulation

Experimental

Group B will be treated with First Relief Treatment at sweep stimulation.

干预措施: First Relief Treatment (Device)

Placebo

Experimental

Group C will be treated with First Relief Treatment, receiving a placebo.(dummy device with no electrical stimulation)

干预措施: First Relief Treatment (Device)

结局指标

主要结局

Reduction of Neuropathy pain

时间窗: According to the patients condition and other factors expected to reduce pain in 4th week of the treatment

This treatments effective outcome will be, "Percutaneous Electrical Nerve Stimulation therapy will have the ability to reduce the pain and other conditions regarding peripheral neuropathy" which can be verified through "Biothesiometer" parameters.

次要结局

  • Check for delay of Re-occurrence of pain within a short time(90 Days)

研究者

发起方
DyAnsys, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

First Relief Treatment for Peripheral Neuropathy | 临床试验